Merck
-
{
- All
- News
- Videos
- Web Stories
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Germany's Tech Company Merck To Open Semiconductor Base in China
Germany's Merck KGaA said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
US Panel Endorses Merck Covid Pill Amid 'Omicron' Variant Concerns
A panel of health experts appointed by the US government voted to recommend Merck's Covid pill for high-risk adult patients, a new form of treatment that is easy to administer and could prove more able to withstand variants, including Omicron.
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
EU Regulator Backs Merck Covid Pill, Says These Adults Can Take It
The EU's medicines watchdog said on Friday that countries can use Merck's anti-Covid pill in emergencies caused by rising cases, ahead of the treatment's formal approval across the bloc.
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Germany's Tech Company Merck To Open Semiconductor Base in China
Germany's Merck KGaA said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
US Panel Endorses Merck Covid Pill Amid 'Omicron' Variant Concerns
A panel of health experts appointed by the US government voted to recommend Merck's Covid pill for high-risk adult patients, a new form of treatment that is easy to administer and could prove more able to withstand variants, including Omicron.
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
EU Regulator Backs Merck Covid Pill, Says These Adults Can Take It
The EU's medicines watchdog said on Friday that countries can use Merck's anti-Covid pill in emergencies caused by rising cases, ahead of the treatment's formal approval across the bloc.
